INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0

CUSIP: 45773HAB8

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Debt / NOTE 6.500% 3/0
Market price (% of par)
499.44%
Total 13F principal
$62,500,000
Principal change
-$13,123,000
Total reported market value
$312,090,000
Number of holders
11
Value change
-$32,691,704
Number of buys
1
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45773HAB8?
CUSIP 45773HAB8 identifies 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 as of Q2 2020

As of 30 Jun 2020, INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $62,500,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Context Capital Management, LLC, D. E. Shaw & Co., Inc., CNH PARTNERS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, WOLVERINE ASSET MANAGEMENT LLC, CVI Holdings, LLC, Polygon Management Ltd., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GABELLI FUNDS LLC. This page lists 11 institutional bondholders reporting positions for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.